Central Aortic Pressure and Arterial Stiffness in Parkinson’s Disease: A Comparative Study

Table 2

Hemodynamic data of participants.

	Control group	PD (before LD)	PD (after LD)	-value	-value
SBP (mm·Hg)	141.15 ± 20.25	151.64 ± 31.39	138.21 ± 18.94	0.01	≤0.001
DBP (mm·Hg)	82.97 ± 12.03	87.36 ± 18.72	77.58 ± 13.47	NS	≤0.001
PP (mm·Hg)	58.12 ± 12.86	64.37 ± 17.16	60.75 ± 12.82	0.01	0.03
HR (minute)	73.01 ± 9.40	77.10 ± 12.70	78.80 ± 12.80	0.02	NS
AI (%)	−16.49 ± 26.68	−13.83 ± 28.74	−21.60 ± 25.61	NS	0.01
CAP (mm·Hg)	137.98 ± 23.83	148.49 ± 31.52	129.60 ± 20.70	0.02	≤0.001

AI: augmentation index; CAP: central aortic pressure; DBP: diastolic blood pressure; HR : heart rate; LD: levodopa; NS: nonsignificant; PP: pulse pressure; SBP : systolic blood pressure. p₁; control group vs PD before LD intake; p₂: PD before LD vs PD after LD intake. Bold numbers indicate significance.